11.30am – 12.15pm AEST, 11 June 2026 ‐ 45 mins
Session
Women’s health represents one of the most underfunded areas in healthcare, despite its scale and impact. This session will explore where the key gaps exist, why capital has historically been under-allocated, and where new opportunities are emerging across research, innovation and
care delivery.



Clinical Director, BreastScreen, St Vincent's Hospital Melbourne


General Partner, Scale Investors
Roo Harris is a leader at the intersection of venture capital and diversity. As the co-owner of Scale Investors, she is a driving force behind investments in women-led startups.
With a background in commercial law and a global career that includes advising Qatar’s ruling family on venture deals, Roo has a unique perspective on how capital can be a powerful lever for both economic and social change. This experience fueled her belief in conscious capital - a human-centered model of capitalism that is both relational and sustainable - and ignited a passion for impact innovation, particularly in the care and climate sectors.
Beyond her work at Scale Investors, Roo is a staunch advocate for the neurodivergent and disability communities, serving on the boards of several disability tech startups. She is also a member of the advisory board for the T-EDI Standards (Tech Council of Australia) and Just Gold's Autistic Pride Day initiative. Roo is an active participant in Equity Clear, a gender transparency initiative spearheaded by Scale Investors, which was recently recognized on Fortune's "Change the World" list.
Roo believes that achieving impact doesn't require returns to be concessionary, a philosophy backed by her long history of startup investing, which includes an early 27x return.

Chief Executive Officer , Baymatob
Tara, GAICD, MBA, B.Eng, B.MedSci is a MedTech executive and CEO of Baymatob, dedicated to advancing maternal and fetal health through AI-enabled, clinically actionable diagnostics. Combining 20+ years of experience in deep-tech commercialisation with a background in navigating complex regulatory pathways, she scales companies to global markets. A staunch advocate for innovation in women’s health, she serves on multiple industry boards and lectures on translating science into real-world impact.
Co-Founder , Metluma
Georgie Drury is Co-Founder and CEO of Metluma, a doctor-led, technology-enabled women's health company helping women better navigate peri-/menopause and midlife health, with plans to expand into endometriosis, surgical menopause and other underserved women's health conditions. A passionate advocate for health equity, Georgie believes data, technology and personalised care can help shape the future of healthcare and help close the gender health gap.
In 2024, Metluma was recognised at the Garmin Health Awards for its innovative use of data to drive health outcomes and behaviour change. More recently, the company launched the 2026 Australian Menopause Experience Report, helping shine a light on the lived experiences, symptom burden and health impacts facing women across Australia. Georgie is committed to turning data into insights that influence research, policy and better health outcomes for women globally.
Prior to Metluma, Georgie founded Springday (now part of APM), a digital wellbeing platform that scaled across 13 countries. She is also a regular speaker, mentor and advisor to emerging founders and women pursuing careers in STEM.
Outside of work, Georgie is a keen knitter, skier and sailor, including competing in the iconic Sydney to Hobart Yacht Race.